Your browser is no longer supported. Please, upgrade your browser.
ATHE Alterity Therapeutics Limited daily Stock Chart
Alterity Therapeutics Limited
Index- P/E- EPS (ttm)-0.64 Insider Own18.70% Shs Outstand15.36M Perf Week-9.60%
Market Cap38.20M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float15.34M Perf Month-10.04%
Income-9.50M PEG- EPS next Q- Inst Own3.00% Short Float0.03% Perf Quarter20.93%
Sales- P/S- EPS this Y25.00% Inst Trans-0.79% Short Ratio0.00 Perf Half Y189.86%
Book/sh0.33 P/B5.53 EPS next Y- ROA-92.10% Target Price- Perf Year58.79%
Cash/sh- P/C- EPS next 5Y- ROE-117.50% 52W Range0.28 - 5.15 Perf YTD134.12%
Dividend- P/FCF- EPS past 5Y-5.10% ROI- 52W High-64.54% Beta1.54
Dividend %- Quick Ratio3.60 Sales past 5Y- Gross Margin- 52W Low552.18% ATR0.16
Employees12 Current Ratio3.60 Sales Q/Q- Oper. Margin- RSI (14)37.73 Volatility9.31% 7.45%
OptionableNo Debt/Eq0.00 EPS Q/Q2.90% Profit Margin- Rel Volume0.06 Prev Close1.91
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume2.06M Price1.83
Recom- SMA20-12.02% SMA50-18.75% SMA20056.23% Volume117,931 Change-4.39%
Aug-05-20 03:10PM  
Aug-04-20 09:07AM  
Aug-03-20 09:33PM  
Jul-30-20 06:49PM  
Jul-01-20 08:12AM  
Jun-29-20 11:14PM  
May-20-20 08:58PM  
Apr-30-20 04:35AM  
Apr-21-20 05:50PM  
Feb-21-20 07:15PM  
Nov-11-19 10:30PM  
Sep-12-19 11:07PM  
Jul-29-19 08:00AM  
Jul-11-19 09:31PM  
May-06-19 08:00AM  
May-03-19 08:00AM  
Alterity Therapeutics Limited researches and develops therapeutic drugs for the treatment of Parkinsonian's disease and other neurodegenerative diseases in Australia. The company's lead drug candidates is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 for used as an antimicrobial agent. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. The company was founded in 1997 and is based in Melbourne, Australia.
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 All Rights Reserved.